Concepedia

Dvorit Samid

DS

Statistics

Publications

54

Citations

5.3K

H-Index

32

Active since

1984

Affiliations

National Cancer Institute(Current)

National Institutes of Health

University of Virginia

Uniformed Services University of the Health Sciences

Johns Hopkins University

Dvorit Samid is an author at National Cancer Institute specializing in medicine, oncology, and pharmacology.

Publications per year

1984–2005

54

Publications

54

Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma.

James G. Herman, Farida Latif, Y Weng et al. · Proceedings of the National Academy of Sciences · 1994 · 1.5K citations

Medicine, Genetics, Oncology +17

Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer.

Alain Thibault, Dvorit Samid, A Tompkins et al. · PubMed · 1996 · 361 citations

Medicine, Oncology, Pharmacology +10

Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2'-deoxycytidine.

Jeffrey S. Weber, Michael L. Salgaller, Dvorit Samid et al. · PubMed · 1994 · 296 citations

Life Sciences, Molecular Biology, Oncology +16

Cinnamic acid: A natural product with potential use in cancer intervention

Lei Liu, W. Robert Hudgins, Sonsoles Shack et al. · International Journal of Cancer · 1995 · 198 citations

Medicine, Cancer Biology, Oncology +17

A phase I and pharmacokinetic study of intravenous phenylacetate in patients with cancer.

Alain Thibault, Michael R. Cooper, William D. Figg et al. · PubMed · 1994 · 157 citations

Pharmacy, Pharmacokinetics, Pharmacology +12

1–5 of 54